2016 Q2 Form 10-Q Financial Statement

#000156459016022075 Filed on August 02, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q4 2015 Q2
Revenue $182.0K $226.0K $110.0K
YoY Change 65.45% -75.8% -45.27%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.670M $2.370M $2.300M
YoY Change 16.09% 10.75% -19.58%
% of Gross Profit
Research & Development $12.08M $8.950M $5.146M
YoY Change 134.69% 63.92% 13.35%
% of Gross Profit
Depreciation & Amortization $70.00K $140.0K $120.0K
YoY Change -41.67% -22.22% -42.86%
% of Gross Profit
Operating Expenses $14.82M $11.32M $5.146M
YoY Change 188.01% 48.95% -30.37%
Operating Profit -$14.64M -$11.09M -$7.889M
YoY Change 85.56% 66.32% 9.69%
Interest Expense $1.000K $20.00K -$45.00K
YoY Change -102.22% -105.0% -25.0%
% of Operating Profit
Other Income/Expense, Net $1.000K $10.00K -$1.680M
YoY Change -100.06% -101.54% 1020.0%
Pretax Income -$14.62M -$11.06M -$10.41M
YoY Change 40.41% 43.26% 40.68%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.457M -$3.169M -$10.41M
YoY Change -57.19% -58.92% 40.63%
Net Earnings / Revenue -2448.9% -1402.21% -9465.45%
Basic Earnings Per Share
Diluted Earnings Per Share -$466.5K -$345.3K -$317.3K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2015 Q4 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.80M $88.00M $2.400M
YoY Change 2558.33% 6185.71%
Cash & Equivalents $63.84M $88.00M $2.397M
Short-Term Investments
Other Short-Term Assets $400.0K $1.100M $300.0K
YoY Change 33.33% 450.0%
Inventory
Prepaid Expenses
Receivables $0.00 $69.00K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $64.26M $89.19M $2.700M
YoY Change 2280.15% 5436.06%
LONG-TERM ASSETS
Property, Plant & Equipment $561.0K $624.0K $3.500M
YoY Change -83.97% -83.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.934M $1.722M $5.200M
YoY Change -62.81% 1465.45%
Total Long-Term Assets $2.519M $2.346M $16.30M
YoY Change -84.55% -79.31%
TOTAL ASSETS
Total Short-Term Assets $64.26M $89.19M $2.700M
Total Long-Term Assets $2.519M $2.346M $16.30M
Total Assets $66.78M $91.53M $19.00M
YoY Change 251.49% 606.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.800M $3.262M $11.50M
YoY Change -14.78% 59.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $46.60M
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $2.200M
YoY Change -100.0%
Total Short-Term Liabilities $9.823M $7.726M $63.00M
YoY Change -84.41% 12.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $6.700M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $200.0K $245.0K $30.20M
YoY Change -99.34% -94.47%
Total Long-Term Liabilities $200.0K $245.0K $36.90M
YoY Change -99.46% -96.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.823M $7.726M $63.00M
Total Long-Term Liabilities $200.0K $245.0K $36.90M
Total Liabilities $10.05M $7.971M $99.90M
YoY Change -89.94% -89.18%
SHAREHOLDERS EQUITY
Retained Earnings -$202.0M -$196.0M
YoY Change
Common Stock $122.1M $117.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$79.52M -$77.97M -$80.90M
YoY Change
Total Liabilities & Shareholders Equity $66.78M $91.53M $19.00M
YoY Change 251.49% 606.76%

Cashflow Statement

Concept 2016 Q2 2015 Q4 2015 Q2
OPERATING ACTIVITIES
Net Income -$4.457M -$3.169M -$10.41M
YoY Change -57.19% -58.92% 40.63%
Depreciation, Depletion And Amortization $70.00K $140.0K $120.0K
YoY Change -41.67% -22.22% -42.86%
Cash From Operating Activities -$11.56M -$8.970M -$8.780M
YoY Change 31.66% 28.51% 21.27%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$60.00K -$30.00K
YoY Change 200.0% -700.0% 200.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $30.00K
YoY Change -84.21%
Cash From Investing Activities -$80.00K -$40.00K -$30.00K
YoY Change 166.67% -120.0% 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K 0.000 10.44M
YoY Change -100.19% -100.0% 19.86%
NET CHANGE
Cash From Operating Activities -11.56M -8.970M -8.780M
Cash From Investing Activities -80.00K -40.00K -30.00K
Cash From Financing Activities -20.00K 0.000 10.44M
Net Change In Cash -11.66M -9.010M 1.630M
YoY Change -815.34% -2750.0% 11.64%
FREE CASH FLOW
Cash From Operating Activities -$11.56M -$8.970M -$8.780M
Capital Expenditures -$90.00K -$60.00K -$30.00K
Free Cash Flow -$11.47M -$8.910M -$8.750M
YoY Change 31.09% 27.47% 21.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
2308000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
69000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1114000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
89186000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
624000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
423000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
64264000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
561000
CY2016Q2 us-gaap Due From Employees Noncurrent
DueFromEmployeesNoncurrent
24000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1934000
CY2016Q2 us-gaap Assets
Assets
66783000
CY2016Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9490000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
182000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
110000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19828000
us-gaap Net Income Loss
NetIncomeLoss
-8309000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000
us-gaap Depreciation
Depreciation
247000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-691000
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10160000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-10412000
us-gaap Depreciation
Depreciation
148000
us-gaap Share Based Compensation
ShareBasedCompensation
1306000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1673000
CY2015Q4 us-gaap Assets
Assets
91532000
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6627000
CY2015Q4 vtvt Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
880000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7726000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
245000
CY2015Q4 us-gaap Liabilities
Liabilities
7971000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
161531000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
117686000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
91532000
us-gaap Sales Revenue Net
SalesRevenueNet
558000
CY2015Q4 us-gaap Due From Employees Noncurrent
DueFromEmployeesNoncurrent
49000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-195985000
us-gaap Operating Expenses
OperatingExpenses
28737000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-77970000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7889000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
42000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-90000
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
-1000
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
230000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
261000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1609000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2863000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2466000
vtvt Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
-568000
vtvt Increase Decrease In Accounts Payable And Accrued Liabilities Related Parties
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedParties
1859000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1110000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-198000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
440000
CY2016Q2 vtvt Accounts Payable And Accrued Expenses Related Party
AccountsPayableAndAccruedExpensesRelatedParty
312000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
219000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9823000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
230000
CY2016Q2 us-gaap Liabilities
Liabilities
10053000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
136250000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
122137000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-201986000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
-79520000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66783000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12077000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5146000
CY2016Q2 vtvt Research And Development Expense Related Party
ResearchAndDevelopmentExpenseRelatedParty
72000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4292000
CY2016Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
21000
CY2015Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-45000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1339000
us-gaap Profit Loss
ProfitLoss
-28137000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1306000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3145000
vtvt Change In Fair Value Of Contingent Distribution
ChangeInFairValueOfContingentDistribution
695000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
27000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
48000
vtvt Bad Debt Expense Recovery Related Party
BadDebtExpenseRecoveryRelatedParty
230000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000
us-gaap Increase Decrease In Due From Employee Current
IncreaseDecreaseInDueFromEmployeeCurrent
-25000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-930000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24055000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18154000
us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
4000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19276000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-83000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-33000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1306000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
76000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-24000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19200000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24162000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1013000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1384000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2397000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3145000
vtvt Non Cash Deferred Offering Costs
NonCashDeferredOfferingCosts
2368000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, the Company evaluates its estimates, including those related to the grant date fair value of equity awards, the fair value of the Class B Common Stock, the useful lives of property and equipment, the fair value of the Company&#8217;s membership units, the fair value of redeemable preferred units, the fair value of derivative liabilities, and the fair value of the Company&#8217;s debt, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions. The balances of these cash accounts frequently exceed insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no accounts receivable balances outstanding as of June&#160;30, 2016.&nbsp;&nbsp;Accounts receivable at December&#160;31, 2015 were $0.1 million with one customer representing 100% of this balance.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Two customers represented 100% of the revenue earned during the three and six months ended June&#160;30, 2016. One customer represented 100% of the revenue during the three and six months ended June&#160;30, 2015.</p></div>
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5600000
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.06
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
22000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
971934
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
122500
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1094434
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16732
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y1M6D
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1046316
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.81
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.70
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.16
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
10.77
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
699000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of Class A Common Stock and Class B Common Stock are entitled to one vote for each share held on all matters submitted to stockholders for their vote or approval.
CY2016Q2 vtvt Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
136300000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
vtvt Percentage Of Amount Of Cash Savings
PercentageOfAmountOfCashSavings
0.85

Files In Submission

Name View Source Status
0001564590-16-022075-index-headers.html Edgar Link pending
0001564590-16-022075-index.html Edgar Link pending
0001564590-16-022075.txt Edgar Link pending
0001564590-16-022075-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gfrff0nap0rk000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtvt-10q_20160630.htm Edgar Link pending
vtvt-20160630.xml Edgar Link completed
vtvt-20160630.xsd Edgar Link pending
vtvt-20160630_cal.xml Edgar Link unprocessable
vtvt-20160630_def.xml Edgar Link unprocessable
vtvt-20160630_lab.xml Edgar Link unprocessable
vtvt-20160630_pre.xml Edgar Link unprocessable
vtvt-ex311_9.htm Edgar Link pending
vtvt-ex312_8.htm Edgar Link pending
vtvt-ex321_6.htm Edgar Link pending
vtvt-ex322_7.htm Edgar Link pending